Atlas Trials

Efficacy of Targeted Therapy Combined Chemotherapy in Advanced EGFR Positive NSCLC Patients

Clinical trial NCT04552613 · COMPLETED

Trial details

NCT number
NCT04552613
Sponsor
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Non-small-lung-cell CancerNSCLCEGFR Gene Mutation
Start date
2020-11-23
Primary completion
2023-09-24
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.